Dr. Jonathan Snipes, MD

Dr. Jonathan Snipes serves as Medical Director at PeptideRx (rxpepsdirect.com), where he sets the clinical standards for the compounded peptide protocols we prescribe and oversees the review process for every new patient intake. His role is to make sure each protocol fits the patient, that contraindications are caught before a script is written, and that every prescription falls inside the 503A patient-specific compounding pathway.

Before joining PeptideRx, Dr. Snipes built his clinical practice around individualized hormone and metabolic care, with particular focus on patients seeking pharmaceutical-grade options outside the traditional brand-name pathway. He has reviewed thousands of compounded protocols across testosterone replacement, GLP-1 weight management, peptide therapy for recovery, and longevity-focused stacks. That breadth shapes how PeptideRx writes its dosing guides and contraindication checks.

On the clinical side, Dr. Snipes maintains an active medical license, keeps a current National Provider Identifier (NPI 1821250077), and personally signs off on the medical guidelines that appear across the PeptideRx catalog. He believes the right way to bring compounded peptides to market is to pair pharmacy-direct pricing with real medical oversight, not to remove either side of that equation.